2025年8月6日,北京大学药学院药事管理与临床药学系管晓东研究员团队与美国耶鲁大学、哈佛大学、英国伦敦政治经济学院的合作研究成果Strength of evidence supporting cancer drug approvals in China, 2017–21:a retrospective analy...2025年8月6日,北京大学药学院药事管理与临床药学系管晓东研究员团队与美国耶鲁大学、哈佛大学、英国伦敦政治经济学院的合作研究成果Strength of evidence supporting cancer drug approvals in China, 2017–21:a retrospective analysis在国际肿瘤学权威期刊《柳叶刀·肿瘤学》(The Lancet Oncology)在线发表。该研究系统评估了2017年至2021年中国获批肿瘤药物的关键临床试验证据质量,是目前首个针对支持中国肿瘤药物监管决策证据强度的实证研究。展开更多
Acute fatty liver of pregnancy(AFLP)is a rare but critical obstetric-specific disease with a high fatality rate,posing a serious threat to the safety of mothers and infants.These guidelines were specially formulated t...Acute fatty liver of pregnancy(AFLP)is a rare but critical obstetric-specific disease with a high fatality rate,posing a serious threat to the safety of mothers and infants.These guidelines were specially formulated to standardize AFLP clinical pathways and to improve maternal and infant outcomes.Based on a two-round questionnaire survey,the guideline development team identified the following nine clinical issues that clinicians were most concerned about,and developed recommendations for each of them:prenatal outpatient screening for AFLP,diagnosis,preoperative risk assessment,delivery modes and timing,anesthesia methods,perinatal complications,selecting AFLP patients for artificial liver treatment,prognostic assessment,and monitoring during treatment.The guidelines cover the key issues related to AFLP diagnosis and treatment that concern clinicians.展开更多
文摘2025年8月6日,北京大学药学院药事管理与临床药学系管晓东研究员团队与美国耶鲁大学、哈佛大学、英国伦敦政治经济学院的合作研究成果Strength of evidence supporting cancer drug approvals in China, 2017–21:a retrospective analysis在国际肿瘤学权威期刊《柳叶刀·肿瘤学》(The Lancet Oncology)在线发表。该研究系统评估了2017年至2021年中国获批肿瘤药物的关键临床试验证据质量,是目前首个针对支持中国肿瘤药物监管决策证据强度的实证研究。
基金This work was supported by the Discipline Construction Funds of Xiangya Hospital Central South University.
文摘Acute fatty liver of pregnancy(AFLP)is a rare but critical obstetric-specific disease with a high fatality rate,posing a serious threat to the safety of mothers and infants.These guidelines were specially formulated to standardize AFLP clinical pathways and to improve maternal and infant outcomes.Based on a two-round questionnaire survey,the guideline development team identified the following nine clinical issues that clinicians were most concerned about,and developed recommendations for each of them:prenatal outpatient screening for AFLP,diagnosis,preoperative risk assessment,delivery modes and timing,anesthesia methods,perinatal complications,selecting AFLP patients for artificial liver treatment,prognostic assessment,and monitoring during treatment.The guidelines cover the key issues related to AFLP diagnosis and treatment that concern clinicians.
